Crossmark

Efficacy and toxicity profile of pegylated liposomal doxorubicin in patients with advanced ovarian cancer

Crossref DOI link: https://doi.org/10.1007/s00404-015-3913-9

Published Online: 2015-10-26

Published Print: 2016-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mayer, Christine

Brucker, Janina

Schuetz, Florian

Domschke, Christoph

Bechstein, Sarah

Heil, Jörg

Golatta, Michael

Wallwiener, Markus

Sohn, Christof

Schneeweiss, Andreas

Rom, Joachim
License Information

Text and Data Mining valid from 2015-10-26